Document: NUREG-0800
Document ID: a55c61ec-57c4-4f3d-b403-d27c8f7c6427
Document Type: srp
Title: SOURCE TERMS
Source: NUREG-0800
Source URL: https://www.nrc.gov/docs/ML0707/ML070790010.pdf
Revision Date: 2023-06
Chapter: 11
Section ID: 11.1
CFR Part: 
CFR Title: 

Content:
radioactive materials in effluents from nuclear power plants. • Regulatory Guide 1.140, as it relates to the design, testing, and maintenance of normal ventilation exhaust system air filtration and adsorption units at nuclear power plants. Specific SRP criteria are as follows: 1. All normal and potential sources of radioactive effluent delineated above in Subsection I will be considered. 2. For each source of liquid and gaseous waste considered above in Subsection I.1, the volumes and concentrations of radioactive material given for normal operation and anticipated operational occurrences should be consistent with those given in NUREG-0016 or NUREG-0017. 3. Decontamination factors for inplant control measures used to reduce gaseous effluent releases to the environment, such as iodine removal systems and high-efficiency particulate air (HEPA) filters for building ventilation exhaust systems and containment internal cleanup systems should be consistent with those given in Regulatory Guide 1.140. The building mixing efficiency for containment internal cleanup should be consistent with NUREG-0017. 4. Decontamination factors for inplant control measures used to reduce liquid effluent releases to the environment, such as filters, demineralizers and evaporators, should be consistent with those given in NUREG-0016 or NUREG-0017. 5. Radwaste augments used in the calculation of effluent releases to the environment are consistent with the findings of a cost-benefit analysis, which may be performed using the guidance of Regulatory Guide 1.110. The provisions that require a cost-benefit analysis are stated in Section II.D of Appendix I to 10 CFR Part 50. 6. Effluent concentration limits at the boundary of the unrestricted area do not exceed the values specified in Table 2 of Appendix B to 10 CFR Part 20. 7. The source terms result in meeting the design objectives for doses in unrestricted areas as set forth in Appendix I to 10 CFR Part 50. 11.1-5 Revision 3 - March 2007 8.